These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38127066)

  • 21. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.
    Basu S; Mak T; Ulferts R; Wu M; Deegan T; Fujisawa R; Tan KW; Lim CT; Basier C; Canal B; Curran JF; Drury LS; McClure AW; Roberts EL; Weissmann F; Zeisner TU; Beale R; Cowling VH; Howell M; Labib K; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2481-2497. PubMed ID: 34198328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes.
    Ornelas MY; Thomas AY; Johnson Rosas LI; Scoville RO; Mehta AP
    ACS Synth Biol; 2022 Nov; 11(11):3759-3771. PubMed ID: 36331143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
    Zhao H; Liu J; He L; Zhang L; Yu R; Kang C
    Biochem Biophys Res Commun; 2022 Oct; 626():114-120. PubMed ID: 35988295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into complex formation by SARS-CoV-2 nsp10 and nsp14.
    Sele C; Krupinska E; Andersson Rasmussen A; Ekström S; Hultgren L; Lou J; Kozielski F; Fisher SZ; Knecht W
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(8):798-812. PubMed ID: 38422227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors.
    Riccio AA; Sullivan ED; Copeland WC
    J Biol Chem; 2022 Jan; 298(1):101518. PubMed ID: 34942146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16.
    Kozielski F; Sele C; Talibov VO; Lou J; Dong D; Wang Q; Shi X; Nyblom M; Rogstam A; Krojer T; Fisher Z; Knecht W
    RSC Chem Biol; 2022 Jan; 3(1):44-55. PubMed ID: 35128408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases.
    Samrat SK; Bashir Q; Zhang R; Huang Y; Liu Y; Wu X; Brown T; Wang W; Zheng YG; Zhang QY; Chen Y; Li Z; Li H
    Emerg Microbes Infect; 2023 Dec; 12(1):2204164. PubMed ID: 37060263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Basis for Inhibition of the SARS-CoV-2 nsp16 by Substrate-Based Dual Site Inhibitors.
    Kalnins G; Rudusa L; Bula AL; Zelencova-Gopejenko D; Bobileva O; Sisovs M; Tars K; Jirgensons A; Jaudzems K; Bobrovs R
    ChemMedChem; 2024 Dec; 19(24):e202400618. PubMed ID: 39258386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
    Maurya SK; Maurya AK; Mishra N; Siddique HR
    J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.
    Alnomasy SF; Alotaibi BS; Aldosari ZM; Mujamammi AH; Alzamami A; Anand P; Akhter Y; Khan FR; Hasan MR
    Comb Chem High Throughput Screen; 2023; 26(6):1196-1203. PubMed ID: 35975856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
    Silva JRA; Urban J; Araújo E; Lameira J; Moliner V; Alves CN
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
    Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.
    Sk MF; Jonniya NA; Roy R; Poddar S; Kar P
    Front Mol Biosci; 2020; 7():590165. PubMed ID: 33330626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches.
    Faisal S; Badshah SL; Kubra B; Sharaf M; Emwas AH; Jaremko M; Abdalla M
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mn
    Minasov G; Rosas-Lemus M; Shuvalova L; Inniss NL; Brunzelle JS; Daczkowski CM; Hoover P; Mesecar AD; Satchell KJF
    Sci Signal; 2021 Jun; 14(689):. PubMed ID: 34131072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.
    Ke M; Chen Y; Wu A; Sun Y; Su C; Wu H; Jin X; Tao J; Wang Y; Ma X; Pan JA; Guo D
    Virus Res; 2012 Aug; 167(2):322-8. PubMed ID: 22659295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV.
    Sarma H; Sastry GN
    ACS Omega; 2022 Aug; 7(34):30003-30022. PubMed ID: 36035077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
    Azad GK
    Biochem Biophys Rep; 2020 Dec; 24():100833. PubMed ID: 33072893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.
    Wu K; Guo Y; Xu T; Huang W; Guo D; Cao L; Lei J
    Molecules; 2024 May; 29(10):. PubMed ID: 38792173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.